Johnson & Johnson

HORSHAM, PA, April 24, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of two

Johnson & Johnson fully endorses the goals of the Global Collaboration to Accelerate Development, Production and Equitable Access to New

NEW BRUNSWICK, N.J., April 23, 2020 - Johnson & Johnson (the Company) (NYSE: JNJ) today announced a collaboration between the

April 22, 2020, Seattle, WA – A network of leading international organizations announced today the creation of an advocacy initiative

HORSHAM, Pa., April 21, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and

New Brunswick, N.J. (April 14, 2020) – Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2020. The Company

New Brunswick, N.J. (April 14, 2020) – Johnson & Johnson today announced that its Board of Directors has declared a

SOUTH SAN FRANCISCO, CA, April 3, 2020 – Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson,

NEW BRUNSWICK, N.J., – April 1, 2020 – Johnson & Johnson (NYSE: JNJ) today announced that, in light of the

NEW BRUNSWICK, NJ [March 31, 2020] – Johnson & Johnson (NYSE: JNJ) today announced that the 2020 Annual Meeting of

NEW BRUNSWICK, N.J., March 30, 2020 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced the selection of a

RARITAN, NJ, March 28, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the VOYAGER PAD study

RARITAN, N.J., March 20, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that it will unveil

Cork, Ireland, March 20, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that Health Canada has

Anecdotal, unsubstantiated reports claim that darunavir has antiviral effect against COVID-19 Johnson & Johnson has no evidence that darunavir has

In our role as a global health leader, Johnson & Johnson is closely monitoring the COVID-19 (coronavirus) situation and taking

NEW BRUNSWICK, N.J., March 13, 2020 – Johnson & Johnson today announced that its Janssen Pharmaceutical Companies have entered a

CORK, IRELAND, March 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson presented new data from its global

CORK, IRELAND, March 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson presented new data from the global

RARITAN, NJ, March 10, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food

RARITAN, NJ, March 2, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Medicines

In our role as a global health leader, Johnson & Johnson is closely monitoring the COVID-19 (coronavirus) situation and taking

27 February 2020 – Today a consortium of philanthropic, non-profit and private sector organizations launched a collaboration that aims to

New Brunswick, NJ (February 26, 2020) — Johnson & Johnson (NYSE: JNJ) will participate in the Barclays Global Healthcare Conference

New Brunswick, NJ, February 25, 2020 — Johnson & Johnson (NYSE: JNJ) today announced that the Janssen Pharmaceutical Companies of